Welcome to our dedicated page for Primerica SEC filings (Ticker: PRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Primerica, Inc. (NYSE: PRI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Primerica is a financial services company serving middle-income households in North America, and its filings offer detail on how its term life insurance and investment and savings products businesses operate.
Among the most important documents for PRI are its annual reports on Form 10-K and quarterly reports on Form 10-Q. These filings typically describe the company’s three primary segments—Term Life Insurance, Investment and Savings Products, and Corporate and Other Distributed Products—and explain how revenues, premiums, commissions and expenses are generated and reported. They also discuss the use of non-GAAP financial measures such as adjusted operating revenues, adjusted net operating income and diluted adjusted operating earnings per share.
Investors can also review current reports on Form 8-K, where Primerica announces material events such as quarterly results releases and the posting of supplemental financial information. These 8-K filings often reference non-GAAP reconciliations and provide links to additional data made available to investors.
For users tracking management and ownership activity, insider transaction reports on Form 4 and related beneficial ownership filings are accessible through the SEC system and can be reviewed alongside other PRI disclosures. Proxy statements on Schedule 14A, when available, typically address topics such as governance and executive compensation.
Stock Titan enhances access to these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly understand segment performance, capital management decisions and adjustments related to non-GAAP measures. Real-time updates from EDGAR ensure that new Primerica filings, including 10-Ks, 10-Qs, 8-Ks and Forms 4, are added as they become available, allowing investors to follow PRI’s regulatory reporting history efficiently.
Schneider Peter W. reported acquisition or exercise transactions in this Form 4 filing.
Primerica, Inc. president Peter W. Schneider received a grant of 3,689 restricted stock units (RSUs) tied to the company’s common stock. Each RSU represents a right to receive one PRI share and vests in three equal annual installments beginning March 1 of the year after the grant. Following this award, Schneider directly holds 10,989 RSUs.
Primerica, Inc. reported that Chief Executive Officer Glenn J. Williams acquired 5,340 restricted stock units (RSUs) on February 20, 2026 as an equity award. Each RSU represents the right to receive one share of Primerica common stock. The RSUs vest in three equal annual installments beginning on March 1 of the year following the grant. After this award, Williams holds 23,992 RSUs directly.
Primerica, Inc. updated its corporate bylaws to formalize when shareholders can demand a special meeting. Under the new Fourth Amended and Restated By-Laws, the board must call a special meeting if one or more shareholders request it and collectively hold at least a majority of the company’s voting power for at least twelve months before the request.
The bylaws add detailed information and documentation requirements for any special meeting request and specify several circumstances when the board is not required to call such a meeting, including timing near an annual meeting, repeat or substantially similar business, or noncompliance with legal and bylaw standards.
Primerica, Inc. chief executive officer and director Glenn J. Williams reported an open-market sale of company stock. On February 17, 2026, he sold 2,500 shares of Primerica common stock at a price of $256.4111 per share. Following this transaction, Williams directly beneficially owned 27,391.995 shares of Primerica common stock.
A person associated with Primerica, Inc. filed a Form 144 notice to sell 2,500 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an aggregate market value of $627,225.00 based on the figures in the notice.
The securities were originally acquired as restricted stock awards from the issuer on 03/01/2025, with the same date listed for acquisition and payment. The notice also states that the filer does not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Primerica, Inc. reported strong fourth quarter and full-year 2025 results, driven by record Investment and Savings Products (ISP) performance and solid term life insurance earnings. Fourth quarter total revenues reached $853.7 million, up 8% from a year earlier. Net income was $197.0 million, an 18% increase, with diluted EPS of $6.13 versus $4.98 from continuing operations in the prior-year quarter. Adjusted operating revenues were $853.5 million, up 8%, while adjusted net operating income rose 16% to $196.9 million and diluted adjusted operating EPS grew 22% to $6.13.
For full-year 2025, net income was $751.2 million, up 4% versus net income from continuing operations in 2024, and diluted EPS increased 9% to $22.91. Adjusted net operating income grew 10% to $751.4 million, and diluted adjusted operating EPS rose 16% to $22.92. Record ISP product sales of $4.1 billion in the quarter were up 24%, and average ISP client asset values increased 14% to $128.2 billion, ending the year at $129 billion. The Term Life segment delivered 2% growth in direct premiums and 5% growth in pre-tax operating income.
Return on stockholders’ equity was 33.2%, and adjusted net operating income return on adjusted stockholders’ equity was 33.5% in the quarter. Primerica returned significant capital to stockholders, completing a $450 million share repurchase authorization in 2025, with the Board approving a new $475 million repurchase program through December 31, 2026. The Board also approved a 15% increase in the quarterly dividend to $1.20 per share, payable March 13, 2026. Primerica Life Insurance Company’s estimated statutory RBC ratio was 455% as of December 31, 2025.
Primerica, Inc. reported that two long-serving board members, Beatriz R. Perez and Gary L. Crittenden, have informed the Board that they will not stand for reelection at the annual meeting of stockholders to be held in May 2026. Ms. Perez has served on the Board for over 11 years and Mr. Crittenden for over 12 years. The company states that each director’s decision is not related to any differences or disagreements with the company, the Board, management, or its operations, policies, or practices. Primerica expresses gratitude for their many years of service and contributions.
Primerica director reports reinvestment of phantom stock dividends. On 12/15/2025, the director acquired 54.139 shares reported as common stock at $258.08 per share through dividends paid on phantom stock that were reinvested in additional phantom stock under the Non-Employee Directors' Deferred Compensation Plan.
After this transaction, the director beneficially owned 19,150.7123 shares in total, held directly. The phantom stock is convertible into common stock on a one-for-one basis according to the plan terms.
Primerica, Inc. reported that one of its directors acquired 36.71 shares of phantom stock on 12/15/2025 at $258.08 per share. The acquisition resulted from dividends on existing phantom stock that were reinvested automatically into additional phantom stock under the Non-Employee Directors' Deferred Compensation Plan.
After this transaction, the director beneficially owned 28,279.7277 shares held directly. The phantom stock is convertible into common stock on a one-for-one basis in accordance with the terms of the plan.
Primerica reported an insider transaction by a director involving phantom stock under the Non-Employee Directors' Deferred Compensation Plan. On 12/15/2025, the director acquired 45.385 additional shares of phantom stock at $258.08 per share, representing dividends that were automatically reinvested. After this transaction, the director beneficially owns 11,307.7937 shares of phantom stock, which are convertible into common stock on a one-for-one basis under the plan.